BioMed Research International / 2016 / Article / Tab 2 / Research Article
Factors Affecting Adverse Drug Reaction Reporting of Healthcare Professionals and Their Knowledge, Attitude, and Practice towards ADR Reporting in Nekemte Town, West Ethiopia Table 2 The knowledge status data of HCPs on ADR reporting in Nekemte town from January 2015 to June 2015.
Variable Category Frequency % Heard about ADR-reporting Yes 83 62.4 No 50 37.6 Information source In-service training 24 27.6 Mass media 6 7.2 Journals or publication 9 10.8 Formal teaching 37 44.5 Peer group 7 8.4 ADRs can be reported on Drugs 43 51.8 Medical devices 12 14.4 Both 28 33.7 Know about existence of yellow card Yes 31 37.4 No 52 62.6 Agents to which ADR is to be reported I do not know 28 33.7 FMHACA 20 24.0 Health center 14 16.8 DTC/local drug monitor 9 10.7 MD/physician 6 7.2 Manufacturer 3 3.6 Department of Pharmacy 3 3.6 Know responsible body Yes 41 30.8 No 92 69.1 To which drug do you expect more unexpected ADRs? Newly marketed drugs 87 65.4 Established drugs 14 10.5 I do not know 32 24.0 ADRs that should be reported All suspected reactions 20 15.0 Unknown/unexpected 33 24.8 Serious 40 30.1 Unexpected therapeutic effects 21 15.7 All 19 13.2 Mostly expected to be reported Expected/labeled 45 33.8 Unexpected/unlabeled 54 40.6 I do not know 34 25.5